These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 8755821)

  • 1. Transfusion of polarized TH2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection.
    VanBuskirk AM; Wakely ME; Orosz CG
    Transplantation; 1996 Jul; 62(2):229-38. PubMed ID: 8755821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine regulation of chronic cardiac allograft rejection: evidence against a role for Th1 in the disease process.
    Piccotti JR; Li K; Chan SY; Eichwald EJ; Bishop DK
    Transplantation; 1999 Jun; 67(12):1548-55. PubMed ID: 10401761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.
    Chan SY; DeBruyne LA; Goodman RE; Eichwald EJ; Bishop DK
    Transplantation; 1995 Apr; 59(8):1155-61. PubMed ID: 7732563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.
    Piccotti JR; Chan SY; Goodman RE; Magram J; Eichwald EJ; Bishop DK
    J Immunol; 1996 Sep; 157(5):1951-7. PubMed ID: 8757314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
    Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
    J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response.
    Simeonovic CJ; Townsend MJ; Karupiah G; Wilson JD; Zarb JC; Mann DA; Young IG
    Cell Transplant; 1999; 8(4):365-73. PubMed ID: 10478716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic conjunctivitis exacerbates corneal allograft rejection by activating Th1 and th2 alloimmune responses.
    Niederkorn JY; Chen PW; Mellon J; Stevens C; Mayhew E
    J Immunol; 2010 Jun; 184(11):6076-83. PubMed ID: 20410484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function.
    Thai NL; Fu F; Qian S; Sun H; Gao L; Wang SC; Demetris AJ; Woo J; Thomson AW; Duquesnoy RJ
    Transplantation; 1995 Jan; 59(2):274-81. PubMed ID: 7530874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantigen-reactive Th1 development in IL-12-deficient mice.
    Piccotti JR; Li K; Chan SY; Ferrante J; Magram J; Eichwald EJ; Bishop DK
    J Immunol; 1998 Feb; 160(3):1132-8. PubMed ID: 9570526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute rejection of cardiac allografts by noncytolytic CD4(+) T cell populations.
    VanBuskirk AM; Wakely ME; Orosz CG
    Transplantation; 1996 Jul; 62(2):300-2. PubMed ID: 8755833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double deficiency for RORγt and T-bet drives Th2-mediated allograft rejection in mice.
    Sabet-Baktach M; Eggenhofer E; Rovira J; Renner P; Lantow M; Farkas SA; Malaisé M; Edtinger K; Shaotang Z; Koehl GE; Dahlke MH; Schlitt HJ; Geissler EK; Kroemer A
    J Immunol; 2013 Oct; 191(8):4440-6. PubMed ID: 24058178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines and rejection of mouse cardiac allografts.
    Carlquist JF; Edelman LS; White W; Shelby J; Anderson JL
    Transplantation; 1996 Oct; 62(8):1160-6. PubMed ID: 8900318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet allograft rejection can be mediated by CD4+, alloantigen experienced, direct pathway T cells of TH1 and TH2 cytokine phenotype.
    Barbara JA; Turvey SE; Kingsley CI; Spriewald BM; Hara M; Witzke O; Morris PJ; Wood KJ
    Transplantation; 2000 Dec; 70(11):1641-9. PubMed ID: 11152227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
    Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
    Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the allograft response by donor specific blood transfusion: association with reduced local TH1 cytokines and nitric oxide but enhanced prostaglandin E2 production.
    Koga S; Luke PP; Specht SM; Rominski B; Jaquins-Gerstl A; Hoffman RA; Thomson AW; Jordan ML
    Transplantation; 2000 Dec; 70(12):1788-96. PubMed ID: 11152112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-33 prolongs murine cardiac allograft survival through induction of TH2-type immune deviation.
    Yin H; Li XY; Jin XB; Zhang BB; Gong Q; Yang H; Zheng F; Gong FL; Zhu JY
    Transplantation; 2010 May; 89(10):1189-97. PubMed ID: 20220570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsiveness.
    Bishop DK; DeBruyne LA; Chan S; Xu S; Eichwald EJ
    Transpl Immunol; 1995 Sep; 3(3):222-8. PubMed ID: 8581410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade.
    Burrell BE; Lu G; Li XC; Bishop DK
    J Immunol; 2009 Jan; 182(1):379-90. PubMed ID: 19109169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.